Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash from Financing Activities (2016 - 2026)

Orthofix Medical has reported Cash from Financing Activities over the past 17 years, most recently at $64.0 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 9926.42% year-over-year to $64.0 million, compared with a TTM value of $63.8 million through Mar 2026, up 123.16%, and an annual FY2025 reading of -$786000.0, down 101.55% over the prior year.
  • Cash from Financing Activities came in at $64.0 million for Q1 2026, up from $2.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $64.0 million in Q1 2026 to a low of -$5.2 million in Q3 2025.
  • Median Cash from Financing Activities over the past 5 years was $2.4 million (2025), compared with a mean of $10.5 million.
  • The sharpest move saw Cash from Financing Activities crashed 301.17% in 2022, then skyrocketed 9926.42% in 2026.
  • Over 5 years, Cash from Financing Activities stood at $1.5 million in 2022, then skyrocketed by 1587.58% to $25.3 million in 2023, then rose by 24.55% to $31.5 million in 2024, then tumbled by 92.45% to $2.4 million in 2025, then skyrocketed by 2591.21% to $64.0 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Cash from Financing Activities are $64.0 million (Q1 2026), $2.4 million (Q4 2025), and -$5.2 million (Q3 2025).